Cytokinetics (CYTK) Stock Highlights

49.86 | -2.41%

2024-11-21 01:20:55

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The treatment is based on small molecules specifically engineered to increase muscle function and contractility.

Statistics

Range Today

49.65 50.95

Volume Today 1.06M

Range 1 Year

30.68 110.25

Volume 1 Year 550.35M

Range 3 Year

25.98 110.25

Volume 3 Year 1.1B

Range 10 Year

4.07 110.25

Volume 10 Year 2.23B

Highlights

Market Capitalization 6.82B (mid)

Floating Shares 117.09M

Current Price 49.86

Price To Earnings -10.51

Price To Revenue 1.97K

Earnings Per Share -5.36

Payout Ratio 0%

Performance

Latest -2.41%

1 Month -8.51%

3 Months -11.55%

6 Months -16.33%

1 Year +52.62%

3 Years +23.2%

5 Years +443.14%

10 Years +1110.19%

Benchmarks

Market Capitalization

24 / 368

Gross Profits

253 / 278

Total Revenue

189 / 300

Total Rank

308 / 368

Free Cashflow

336 / 352

Performance 5 years

15 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.